Neoadjuvant therapies for hepatocellular carcinoma before liver transplantation: A critical appraisal
- 1 December 2006
- journal article
- review article
- Published by Ovid Technologies (Wolters Kluwer Health) in Liver Transplantation
- Vol. 12 (12), 1747-1754
- https://doi.org/10.1002/lt.21018
Abstract
No abstract availableThis publication has 64 references indexed in Scilit:
- Expanded Criteria for Hepatocellular Carcinoma Through Down-Staging Prior to Liver Transplantation: Not Yet ThereSeminars in Liver Disease, 2006
- Percutaneous ablation procedures in cirrhotic patients with hepatocellular carcinoma submitted to liver transplantation: Assessment of efficacy at explant analysis and of safety for tumor recurrenceLiver Transplantation, 2005
- Impact of pretransplantation transarterial chemoembolization on survival and recurrence after liver transplantation for hepatocellular carcinomaLiver Transplantation, 2005
- Resection and Liver Transplantation for Hepatocellular CarcinomaSeminars in Liver Disease, 2005
- Percutaneous radiofrequency ablation of hepatocellular carcinoma as a bridge to liver transplantationHepatology, 2005
- Four‐year follow‐up of a prospective randomized trial of mycophenolate mofetil with cyclosporine microemulsion or tacrolimus following liver transplantationClinical Transplantation, 2004
- 1250 Predictors of drop-out and survival of patients with hepatocellular carcinoma candidates for liver transplantationHepatology, 2003
- Systematic review of randomized trials for unresectable hepatocellular carcinoma: Chemoembolization improves survivalHepatology, 2003
- Clinical Management of Hepatocellular Carcinoma. Conclusions of the Barcelona-2000 EASL ConferenceJournal of Hepatology, 2001
- Arterial chemoembolization before liver transplantation in patients with hepatocellular carcinoma: marked tumor necrosis, but no survival benefit?Journal of Hepatology, 1998